Your browser doesn't support javascript.
loading
A novel protective modality against rotenone-induced Parkinson's disease: A pre-clinical study with dulaglutide.
Khalaf, Marwa M; El-Sayed, Mahmoud M; Kandeil, Mohamed A; Ahmed, Sanaa.
Afiliação
  • Khalaf MM; Pharmacology & Toxicology Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt. Electronic address: marwa.khalaf@pharm.bsu.edu.eg.
  • El-Sayed MM; Pharmacology & Toxicology Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt. Electronic address: mahmoud.awadddd@gmail.com.
  • Kandeil MA; Biochemistry Department, Faculty of Veterinary Medicine, Beni-Suef University, Beni-Suef 62514, Egypt. Electronic address: mohamed.kandeal@vet.bsu.edu.eg.
  • Ahmed S; Pharmacology Department, Faculty of Medicine, Sohag University, Sohag 82524, Egypt. Electronic address: sanaa_ahmed@med.sohag.edu.eg.
Int Immunopharmacol ; 119: 110170, 2023 Jun.
Article em En | MEDLINE | ID: mdl-37075673
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Fármacos Neuroprotetores Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Fármacos Neuroprotetores Idioma: En Ano de publicação: 2023 Tipo de documento: Article